GlassScriptPhysician profile
Grace C Vanesko
NPI 1871579169
$5,185.23
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $409 · 2021: $1,266 · 2022: $1,280 · 2023: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,135.22 | 2019-2023 | Rinvoq, Skyrizi, Linzess |
| Janssen Biotech, INC. | $415.78 | 2019-2023 | Stelara, Simponi Aria, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $324.60 | 2019-2023 | Entyvio |
| Micro-Tech Endoscopy USA, INC. | $263.17 | 2019 | |
| Celgene Corporation | $229.35 | 2021-2023 | Zeposia |
| Pfizer INC. | $207.08 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $163.29 | 2021-2023 | Dificid, Zerbaxa, Recarbrio |
| Ferring Pharmaceuticals INC. | $161.69 | 2019-2023 | Clenpiq |
| Amgen INC. | $143.51 | 2021-2023 | Avsola, Amjevita |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.82 | 2019-2023 | Xifaxan, Trulance |
| Janssen Scientific Affairs, LLC | $110.50 | 2021 | |
| Genzyme Corporation | $83.01 | 2023 | |
| Qol Medical, LLC | $79.96 | 2019-2023 | Sucraid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.09 | 2023 | Cyltezo |
| Nestle Healthcare Nutrition INC. | $74.86 | 2021-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $70.08 | 2021-2023 | Linzess |
| Gilead Sciences, INC. | $64.38 | 2021-2022 | |
| Ucb, INC. | $63.95 | 2019 | |
| Intercept Pharmaceuticals, INC. | $47.78 | 2020-2022 | |
| Ardelyx, INC. | $46.92 | 2022-2023 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $42.28 | 2022-2023 | Dupixent |
| Boston Scientific Corporation | $39.89 | 2022 | |
| Endo Pharmaceuticals INC. | $33.03 | 2019 | |
| Shire North American Group INC | $31.70 | 2019 | |
| Daiichi Sankyo INC. | $31.12 | 2019-2020 | |
| Welch Allyn | $29.52 | 2021 | |
| Lilly USA, LLC | $24.46 | 2023 | |
| Aimmune Therapeutics, INC. | $15.83 | 2023 | |
| Organon LLC | $14.61 | 2022 | |
| Fresenius Kabi USA, LLC | $14.21 | 2023 | Idacio |
| Cumberland Pharmaceuticals, INC. | $13.14 | 2019 | |
| Covidien LP | $12.40 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,061.57 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Vanesko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.